Published in Blood Weekly, January 10th, 2002
The announcement took place during the Society's annual Corporate Friday program, "Application of the New Biology to the Diagnosis and Treatment of Hematologic Malignancies," on December 7, 2001, in Orlando, Florida.
Griffin's early research, funded in part by the Society's SCOR program in 2000, led to this new clinical trial. During his presentation, Griffin discussed some of his team's...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.